FDM PHARMA
Board
1 director, no change since 2021Director (not named in the articles)
since 21-01-2021
term without a fixed end
earlier manager, until 09-02-2021
listed in the 2025 annual accounts, filed on 31-07-2026
Mandates through the years
1 name, the dashed line is todayDirector (not named in the articles)
BoardEarlier
Mandates as a list
-
- Manager, appointed by deed of 25-02-2014, until 09-02-2021
- Director (not named in the articles), appointed by deed of 09-02-2021, still in office
Control
Shareholder
This company
FDM PHARMA
Equity €1.8m
Profit €357,146 in 2025
Capital
- Contribution
- €14,260
- Shares
- 100
- Contribution per share
- €143
- Equity per share
- €18,498 in 2025
- Source
- deed of 09-02-2021
Articles of association
deed of 09-02-2021 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- Moitié cédant moitié acquéreurs proportionnel actions, mêmes formalités si non actionnaires de plein droit
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Friday of June at 20:00
Shareholders
Stated in the deed
deed of 09-02-2021 ↗
Stated in the deed
deed of 31-03-2015 ↗
- associé unique
At incorporation
deed of 25-02-2014 ↗
- 100 shares (100%)
Capital transactions
Capital over time
- 09-02-2021 Converted to unavailable equity · €14,260
- 25-02-2014 Incorporation · €18,600 · 100 shares